EAGLE PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $4.19M, a 6.84% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $16.5M, a 6.12% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.5M, a 15.9% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $19.6M, a 21% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $24.8M, a 12.5% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $16.5M -$3.1M -15.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $19.6M -$5.2M -21% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $24.8M +$2.76M +12.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $22M +$2.92M +15.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $19.1M +$3.65M +23.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $15.4M +$5.66M +58% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $9.77M +$5.72M +141% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $4.05M +$3.45M +568% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $606K +$289K +91.2% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 $317K -$85K -21.1% Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
2012 $402K Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.